Parvovirus B19-related Membranoproliferative Glomerulonephritis Presenting with Positive Glomerular Staining for Nephritis-associated Plasmin Receptor: a Case Report and Review of the Literature

Overview

Journal CEN Case Rep

Specialty Nephrology

Date 2024 Dec 15

PMID 39674998

Authors

Haruka Takahashi

Yukihiro Wada

Takuya Yamazaki

Kazuhiro Takeuchi

Tetsuya Abe

Shokichi Naito

Togo Aoyama

Takashi Sano

Rika Moriya

Takashi Oda

Yasuo Takeuchi

Affiliations

Soon will be listed here.

Abstract

Several cases of glomerulonephritis occurring after infection with human parvovirus B19 (PVB19) have been reported. However, the pathogenesis and clinicopathological features of PVB19-related glomerulonephritis remain elusive. We describe the case of a 34 year-old woman who showed nephrotic syndrome and microscopic hematuria 10 days after PVB19 infection. Blood pressure and renal function were within normal ranges. Laboratory tests showed positive results for anti-PVB19 immunoglobulin (Ig)M antibody and complement 3 (C3) hypocomplementemia. Antibody to streptolysin O (ASO) was slightly elevated, but bacterial cultures yielded no colonies. Light microscopy of renal biopsy was compatible with membranoproliferative glomerulonephritis (MPGN). Immunofluorescence microscopy showed intense staining for C3 and faint staining for IgG on the glomerular capillary wall and paramesangial area. Electron micrography showed subendothelial electron-dense deposits (EDDs), but hump-shaped subepithelial EDDs were not evident. PBV19-DNA was absent from renal tissue. Moreover, glomeruli showed positive staining for nephritis-associated plasmin receptor (NAPlr) and plasmin activity with similar distribution. Around 6 months after PVB19 infection, levels of anti-PVB19 IgM antibody spontaneously tuned negative with an apparent reduction of proteinuria and improvement of hypocomplementemia, although ASO level remained unchanged. This appears to represent the first description of positive glomerular staining for NAPlr in MPGN after PVB19 infection. Based on a review of 27 cases, including our own case, the MPGN lesions could be attributable to PVB19 infection. Clinicopathological features of this case were incompatible with post-streptococcal acute glomerulonephritis. We presume that a PBV19-derived glomerular pathogen that cross-reacts with anti-NAPlr antibody might be involved in the development of PVB19-related MPGN.

Citing Articles

Element analysis applied to investigate acute kidney injury induced by red yeast rice supplement.

Abe M, Ogawa T, Magome N, Ono Y, Tojo A Med Mol Morphol. 2024; 58(1):53-61.

PMID: 39535557 PMC: 11829840. DOI: 10.1007/s00795-024-00411-1.

References

Rohrer C, Gartner B, Sauerbrei A, Bohm S, Hottentrager B, Raab U . Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect. 2008; 136(11):1564-75. PMC: 2870752. DOI: 10.1017/S0950268807009958. View

Kauffmann M, Bobot M, Daniel L, Torrents J, Knefati Y, Moranne O . Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy. BMC Nephrol. 2020; 21(1):260. PMC: 7350584. DOI: 10.1186/s12882-020-01911-9. View

Kupin W . Viral-Associated GN: Hepatitis B and Other Viral Infections. Clin J Am Soc Nephrol. 2016; 12(9):1529-1533. PMC: 5586580. DOI: 10.2215/CJN.09180816. View

Besse W, Mansour S, Jatwani K, Nast C, Brewster U . Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation. BMC Nephrol. 2016; 17(1):125. PMC: 5013576. DOI: 10.1186/s12882-016-0330-7. View

Moudgil A, Nast C, Bagga A, Wei L, Nurmamet A, Cohen A . Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001; 59(6):2126-33. DOI: 10.1046/j.1523-1755.2001.00727.x. View

Magro C, Crowson A, Dawood M, Nuovo G . Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases. J Rheumatol. 2002; 29(6):1227-35. View

Nakazawa T, Tomosugi N, Sakamoto K, Asaka M, Yuri T, Ishikawa I . Acute glomerulonephritis after human parvovirus B19 infection. Am J Kidney Dis. 2000; 35(6):E31. DOI: 10.1016/s0272-6386(00)70070-9. View

Ohtomo Y, Kawamura R, Kaneko K, Yamashiro Y, Kiyokawa N, Taguchi T . Nephrotic syndrome associated with human parvovirus B19 infection. Pediatr Nephrol. 2003; 18(3):280-2. DOI: 10.1007/s00467-002-1056-2. View

Nadasdy T, Hebert L . Infection-related glomerulonephritis: understanding mechanisms. Semin Nephrol. 2011; 31(4):369-75. DOI: 10.1016/j.semnephrol.2011.06.008. View

10.

Wada Y, Kamata M, Miyasaka R, Abe T, Kawamura S, Takeuchi K . Clinico-Pathogenic Similarities and Differences between Infection-Related Glomerulonephritis and C3 Glomerulopathy. Int J Mol Sci. 2023; 24(9). PMC: 10179079. DOI: 10.3390/ijms24098432. View

11.

Nasr S, Radhakrishnan J, DAgati V . Bacterial infection-related glomerulonephritis in adults. Kidney Int. 2013; 83(5):792-803. DOI: 10.1038/ki.2012.407. View

12.

Nasr S, Fidler M, Valeri A, Cornell L, Sethi S, Zoller A . Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol. 2010; 22(1):187-95. DOI: 10.1681/ASN.2010060611. View

13.

Nasr S, Markowitz G, Stokes M, Said S, Valeri A, DAgati V . Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature. Medicine (Baltimore). 2008; 87(1):21-32. DOI: 10.1097/md.0b013e318161b0fc. View

14.

Oda T, Yoshizawa N, Yamakami K, Sakurai Y, Takechi H, Yamamoto K . The role of nephritis-associated plasmin receptor (NAPlr) in glomerulonephritis associated with streptococcal infection. J Biomed Biotechnol. 2012; 2012:417675. PMC: 3477576. DOI: 10.1155/2012/417675. View

15.

Oda T, Yamakami K, Omasu F, Suzuki S, Miura S, Sugisaki T . Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2004; 16(1):247-54. DOI: 10.1681/ASN.2004040341. View

16.

Yoshizawa N, Yamakami K, Fujino M, Oda T, Tamura K, Matsumoto K . Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol. 2004; 15(7):1785-93. DOI: 10.1097/01.asn.0000130624.94920.6b. View

17.

Sethi S, Nester C, Smith R . Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int. 2011; 81(5):434-41. PMC: 4428602. DOI: 10.1038/ki.2011.399. View

18.

Shimohata H, Higuchi T, Ogawa Y, Fujita S, Nagai M, Imaizumi M . Human parvovirus B19-induced acute glomerulonephritis: a case report. Ren Fail. 2012; 35(1):159-62. DOI: 10.3109/0886022X.2012.736068. View

19.

Shirai Y, Miura K, Yabuuchi T, Nagasawa T, Ishizuka K, Takahashi K . Rapid progression to end-stage renal disease in a child with IgA-dominant infection-related glomerulonephritis associated with parvovirus B19. CEN Case Rep. 2020; 9(4):423-430. PMC: 7502115. DOI: 10.1007/s13730-020-00501-w. View

20.

Soderlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K . Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris). 2002; 50(5):307-16. DOI: 10.1016/s0369-8114(02)00307-3. View